The DOI matches its Crossref record.
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
Abstract
Anti-IgE-dependent activation of rat and human mast cells resulted in the preferential generation of the cyclooxygenase products prostaglandin D2 (PGD2) and prostaglandin I2 (PGI2) in the rat and PGD2 in the human. The average net generation of PGD2, determined by gas chromatography-mass spectrometry, was 13.1 ng/10(6) purified rat mast cells and 39.5 ng/10(6) dispersed, enriched human mast cells. After IgE-dependent activation, there was a linear relationship between the net quantities of PGD2 generated and of histamine secreted from dispersed human pulmonary cells when the number of mast cells was varied but the total number of cells was held constant, indicating that it is the number of mast cells participating in IgE-dependent activation, rather than total mast cell number, that determines PGD2 generation. A linear relationship was also shown between PGD2 generation, determined by radioimmunoassay, and the release of the granule marker beta-hexosaminidase from purified rat mast cells on the dose-response portion of the plot of their response to anti-IgE challenge. With higher concentrations of anti-IgE, PGD2 generation from rat mast cells plateaued, whereas net percent beta-hexosaminidase release increased further. In kinetic studies of rat mast cells activated with anti-IgE, the onset (1 to 2 min) and time of maximum generation (5 to 10 min) for PGD2 were delayed relative to the onset (15 to 30 sec) and completion (1 to 2 min) of beta-hexosaminidase release. Thus, the extracellular appearance of PGD2 during IgE-dependent mast cell activation represents a response additional to the secretion of granule-associated mediators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Lewis, R. A., & Austen, K. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111312 · Cited by 656
Self-citationLocal Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin
Soter, N. A., Lewis, R. A., Corey, E. J., & Austen, K. F. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12531738 · Cited by 589
Self-citationHISTAMINE‐INDUCED CORONARY ARTERY SPASM: THE CONCEPT OF ALLERGIC ANGINA
Kounis, N. G., & Zavras, G. M. (1991) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1991.tb10251.x · Cited by 569
Galli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
Xue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N. J., Spits, H., Klenerman, P., & Ogg, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.056 · Cited by 475
Release of Prostaglandin D2into Human Airways during Acute Antigen Challenge
Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J., Gosset, P., Workman, R., Capron, A., & Oates, J. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609253151304 · Cited by 469
Self-citationClinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Self-citationMast Cell Mediators: Their Differential Release and the Secretory Pathways Involved
Moon, T. C., Befus, A. D., & Kulka, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00569 · Cited by 432
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191106 · Cited by 379
Self-citationReversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
TELLIER, P., PAYCHA, F., ANTONY, I., NITENBERG, A., VALEYRE, D., FOULT, J., & BATTESTI, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90536-0 · Cited by 370
The Biology of Eosinophils and Their Role in Asthma
McBrien, C. N., & Menzies-Gow, A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00093 · Cited by 368
Recent advances in the cellular and molecular biology of mast cells
Stevens, R. L., & Frank Austen, K. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90272-7 · Cited by 358
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18910 · Cited by 336
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001) · Blood · doi:10.1182/blood.v98.6.1942 · Cited by 326
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
George, L., & Brightling, C. E. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315609251 · Cited by 326
Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Pettipher, R., Hansel, T. T., & Armer, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2266 · Cited by 317
The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic Men
Hardy, C. C., Robinson, C., Tattersfield, A. E., & Holgate, S. T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110401 · Cited by 316
Evidence That Histamine Is the Causative Toxin of Scombroid-Fish Poisoning
Morrow, J. D., Margolies, G. R., Rowland, J., & Roberts, L. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241102 · Cited by 313
Self-citationProstaglandin D synthase: Structure and function
(2000) · Vitamins & Hormones · doi:10.1016/s0083-6729(00)58022-4 · Cited by 299
Increased Adventitial Mast Cells in a Patient with Coronary Spasm
Forman, M. B., Oates, J. A., Robertson, D., Robertson, R. M., Roberts, L. J., & Virmani, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131807 · Cited by 298
Self-citationBalzar, S., Fajt, M. L., Comhair, S. A. A., Erzurum, S. C., Bleecker, E., Busse, W. W., Castro, M., Gaston, B., Israel, E., Schwartz, L. B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0295oc · Cited by 293
Mediators of immediate hypersensitivity
Wasserman, S. I. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90512-2 · Cited by 288
Xue, L., Gyles, S. L., Wettey, F. R., Gazi, L., Townsend, E., Hunter, M. G., & Pettipher, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6531 · Cited by 261
Cloning and Crystal Structure of Hematopoietic Prostaglandin D Synthase
Kanaoka, Y., Ago, H., Inagaki, E., Nanayama, T., Miyano, M., Kikuno, R., Fujii, Y., Eguchi, N., Toh, H., Urade, Y., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80374-8 · Cited by 258
Mediators of immediate hypersensitivity reactions
Serafin, W. E., & Austen, K. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170106 · Cited by 256
Self-citationTryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response
Castells, M., & Schwartz, L. B. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90005-x · Cited by 160
The ingenious mast cell: contemporary insights into mast cell behavior and function
Dahlin, J. S., Maurer, M., Metcalfe, D. D., Pejler, G., Sagi‐Eisenberg, R., & Nilsson, G. (2022) · Allergy · doi:10.1111/all.14881 · Cited by 147
Douaiher, J., Succar, J., Lancerotto, L., Gurish, M. F., Orgill, D. P., Hamilton, M. J., Krilis, S. A., & Stevens, R. L. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00006-7 · Cited by 131
Yamaki, K., Thorlacius, H., Xie, X., Lindbom, L., Hedqvist, P., & Raud, J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701614 · Cited by 96
Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation
Luna-Gomes, T., Magalhães, K. G., Mesquita-Santos, F. P., Bakker-Abreu, I., Samico, R. F., Molinaro, R., Calheiros, A. S., Diaz, B. L., Bozza, P. T., Weller, P. F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101806 · Cited by 87
Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N., & Ikezawa, Z. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01862.x · Cited by 86
Monitoring mast cell activation by prostaglandin D2 in vivo
Dahlen, S.-E. (2004) · Thorax · doi:10.1136/thx.2004.026641 · Cited by 77
Wong, G. W., Zhuo, L., Kimata, K., Lam, B. K., Satoh, N., & Stevens, R. L. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.124 · Cited by 74
Awad, J. A., Morrow, J. D., & Roberts, L. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90371-9 · Cited by 66
Self-citationShimura, C., Satoh, T., Igawa, K., Aritake, K., Urade, Y., Nakamura, M., & Yokozeki, H. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090111 · Cited by 60
Marone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1555237 · Cited by 62
“PGD2 is the main cyclooxygenase product of activated human mast cells [21,23,69].”
BackgroundKobayashi, Y., Ueki, S., Mahemuti, G., Chiba, T., Oyamada, H., Saito, N., Kanda, A., Kayaba, H., & Chihara, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5744 · Cited by 57
“PGD2 is a major arachidonic acid metabolite mainly released by Ag-activated mast cells (7), and a large amount of PGD2 is generated in the asthmatic lung (8, 9).”
BackgroundButterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.021 · Cited by 41
FcεRI, but Not FcγR, Signals Induce Prostaglandin D2 and E2 Production from Basophils
Ugajin, T., Satoh, T., Kanamori, T., Aritake, K., Urade, Y., & Yokozeki, H. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.023 · Cited by 37
Butterfield, J. H. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.03.008 · Cited by 27
Marhuenda, J., Medina, S., Martínez-Hernández, P., Arina, S., Zafrilla, P., Mulero, J., Oger, C., Galano, J.-M., Durand, T., Solana, A., et al. (2017) · Food Funct. · doi:10.1039/c7fo01081h · Cited by 22
Metadata
- Authors
- Lewis, R. A., Soter, N. A., Diamond, P. T., Austen, K. F., Oates, J. A., & Roberts, L. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1982-10-01
- Volume
- 129
- Issue
- 4
- Pages
- 1627-1631
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1680932833
- Cited by
- 584
- References
- 0
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.